Evolus Inc (EOLS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Evolus Inc (EOLS) is down 0.9% since the beginning of the year. At $7 per share, EOLS is trading 35.4% below its 52-week high of $10. Investors who bought $1,000 worth of EOLS shares 5 years ago would now be looking at an investment worth $472.

Evolus Inc (EOLS) has returned -0.90% so far this year and -28.99% over the past 12 months.

Based on dividend-adjusted daily data since Feb 8, 2018, EOLS's average daily return is +0.10%, while the average monthly return is +3.28%. At this rate, an investment would double in approximately 1.8 years.

Historically, 51% of months were positive and 49% were negative. The best month was May 2018 with a return of +257.7%, while the worst month was Mar 2020 at -51.7%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, EOLS closed higher 48% of trading days. The best single day was Feb 19, 2021 with a return of +71.7%, while the worst single day was Mar 16, 2020 at -28.8%.

Evolus Inc has an annualized alpha of 8.77%, beta of 1.17, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since February 08, 2018.

• This stock participated in 188.03% of S&P 500 Index downside but only 154.11% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

EOLS ranks 26 for risk / return — below 26% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Evolus Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Evolus Inc was 92.41%, occurring on Oct 29, 2020. The portfolio has not yet recovered.

The current Evolus Inc drawdown is 82.88%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Evolus Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Evolus Inc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.